Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure

DL Eizirik, L Pasquali, M Cnop - Nature Reviews Endocrinology, 2020 - nature.com
Loss of functional β-cell mass is the key mechanism leading to the two main forms of
diabetes mellitus—type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) …

The pathogenic “symphony” in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas

MA Atkinson, RG Mirmira - Cell Metabolism, 2023 - cell.com
Summary Type 1 diabetes (T1D) is widely considered to result from the autoimmune
destruction of insulin-producing β cells. This concept has been a central tenet for decades of …

Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial

L Krogvold, IM Mynarek, E Ponzi, FB Mørk… - Nature Medicine, 2023 - nature.com
Previous studies showed a low-grade enterovirus infection in the pancreatic islets of patients
with newly diagnosed type 1 diabetes (T1D). In the Diabetes Virus Detection (DiViD) …

[HTML][HTML] Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis

C Chen, CM Cohrs, J Stertmann, R Bozsak… - Molecular metabolism, 2017 - Elsevier
Background Plasma insulin levels are predominantly the product of the morphological mass
of insulin producing beta cells in the pancreatic islets of Langerhans and the functional …

Viral infections in type 1 diabetes mellitus—why the β cells?

A Op de Beeck, DL Eizirik - Nature Reviews Endocrinology, 2016 - nature.com
Type 1 diabetes mellitus (T1DM) is caused by progressive autoimmune-mediated loss of
pancreatic β-cell mass via apoptosis. The onset of T1DM depends on environmental factors …

Differential insulitic profiles determine the extent of β-cell destruction and the age at onset of type 1 diabetes

P Leete, A Willcox, L Krogvold, K Dahl-Jørgensen… - Diabetes, 2016 - Am Diabetes Assoc
Type 1 diabetes (T1D) results from a T cell–mediated destruction of pancreatic β-cells
following the infiltration of leukocytes (including CD8+, CD4+, and CD20+ cells) into and …

Obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms

KD Corbin, KA Driscoll, RE Pratley, SR Smith… - Endocrine …, 2018 - academic.oup.com
There has been an alarming increase in the prevalence of obesity in people with type 1
diabetes in recent years. Although obesity has long been recognized as a major risk factor …

Targeting ABL-IRE1α signaling spares ER-stressed pancreatic β cells to reverse autoimmune diabetes

S Morita, SA Villalta, HC Feldman, AC Register… - Cell metabolism, 2017 - cell.com
In cells experiencing unrelieved endoplasmic reticulum (ER) stress, the ER transmembrane
kinase/endoribonuclease (RNase)—IRE1α—endonucleolytically degrades ER-localized …

α cell function and gene expression are compromised in type 1 diabetes

M Brissova, R Haliyur, D Saunders, S Shrestha, C Dai… - Cell reports, 2018 - cell.com
Many patients with type 1 diabetes (T1D) have residual β cells producing small amounts of
C-peptide long after disease onset but develop an inadequate glucagon response to …

β cells that resist immunological attack develop during progression of autoimmune diabetes in NOD mice

J Rui, S Deng, A Arazi, AL Perdigoto, Z Liu, KC Herold - Cell metabolism, 2017 - cell.com
Summary Type 1 diabetes (T1D) is a chronic autoimmune disease that involves immune-
mediated destruction of β cells. How β cells respond to immune attack is unknown. We …